Inovio Pharmaceuticals Inc. (INO) Jumps 7.22% on January 28

Equities Staff  |

Inovio Pharmaceuticals Inc. (INO) was among the biggest gainers on the Russell 2000 for Thursday January 28 as the stock popped 7.22% to $5.76, representing a gain of $0.3875 per share. Some 6.08 million shares traded hands on 24,898 trades, compared with an average daily volume of 1.3 million shares out of a total float of 72.18 million. The stock opened at $6.00 and traded with an intraday range of $6.32 to $5.52.

After today's gains, Inovio Pharmaceuticals Inc. reached a market cap of $415.6 million. Inovio Pharmaceuticals Inc. has had a trading range between $10.83 and $4.50 over the last year, and it had a 50-day SMA of $6.40 and a 200-day SMA of $7.34.

Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.

Inovio Pharmaceuticals Inc. is based out of Plymouth Meeting, PA and has some 106 employees. Its CEO is J. Joseph Kim.

For a complete fundamental analysis analysis of Inovio Pharmaceuticals Inc., check out’s Stock Valuation Analysis report for INO. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Level Headed at World Crypto Con - Steve Beauregard CRO Steve Beauregard joins Jack Brewer at World Crypto Con.

Emerging Growth

Goldrea Resources Corp.

Goldrea Resources Corp is engaged in the acquisition, exploration and development of mineral properties located in North America.